|
|
||||||||
-Crystallin
From the National Vision Research Institute of Australia, Carlton, Victoria, Australia.
| Abstract |
|---|
|
|
|---|
METHODS. Bovine lens extract was incubated with 5.2 x
10-8 M [3H]-dexamethasone for 3
hours, and the distribution of label assessed in the soluble and
insoluble fractions after centrifugation. Soluble lens extract was
fractionated using gel permeation chromatography to isolate and
identify proteins involved in the binding. Total lens proteins,
high-molecular-weight proteins, or
-crystallin were exposed to
dexamethasone and the protein bound steroid measured after separation
of free and bound ligand on a gel chromatography column.
Scatchard analysis was used to determine dexamethasone-binding
parameters. Sequence comparisons between bovine
A- and
B-crystallins and glucocorticoid-binding proteins were performed
using a sequence-alignment program.
RESULTS. Of the total dexamethasone bound in lens extract, soluble proteins were
found to account for 52%. The majority of the soluble protein-bound
dexamethasone coeluted with the high-molecular-weight proteins that
consisted mainly of
-crystallin. Binding studies with isolated
proteins showed that
-crystallin accounted for more than 98% of
total soluble dexamethasone binding in the lens. Scatchard analysis of
steroid binding showed it to be a nonspecific partitioning event.
Sequence comparisons between
A- and
B-crystallins and various
glucocorticoid-binding proteins showed the lens proteins to have three
regions of sequence homology with yeast corticosteroid-binding protein.
CONCLUSIONS.
-Crystallin is the principal soluble glucocorticoid binding protein
in the lens. The steroid association is described by nonspecific
partitioning and may be related to the unique structural
characteristics of the protein. The nonspecific association with
-crystallin is not thought to be functional; however, it may aid in
the increased covalent steroid modification observed for this
protein.
| Introduction |
|---|
|
|
|---|
Apart from the cytosolic receptor, several soluble as well as membrane-bound, steroid-binding proteins have been described.8 9 10 Some have been observed in the lens. In 1973, Ono et al.11 described a cortisol-binding protein found in the ß-crystallin fraction of rat lens extract. The protein was implicated in cataract formation, because its level was found to decrease in cataractous human lenses. More recently, Cenedella et al.12 have reported that bovine lens epithelial membranes contain a 28-kDa protein capable of binding progesterone with high affinity.
Lens proteins are also known to covalently bind steroids through their
lysine residues.13
Dickerson et al.14
observed a number of steroids, including progesterone, to bind purified
ß-crystallin. One of the more potent glucocorticoids, dexamethasone,
has also been reported to preferentially bind
-crystallin.15
Although a small amount of lens-soluble
steroid binding can be attributed to covalent interactions, the
majority of the binding is not of this type.7
In the mammalian system, the soluble steroid-binding proteins are principally found in serum and can be classified into three groups, the sex hormonebinding globulin (SHBG), the corticosteroid-binding globulin (CBG), and serum albumin.16 These form noncovalent complexes with steroids through a combination of hydrophobic and hydrophilic forces. This binding, together with high dissociation rates,10 generates a readily dissociable complex, allowing instantaneous control of circulating steroid levels. Because protein-associated steroid is known to be functionally inactive and specific cell membranebinding sites have been reported,17 these serum proteins act as important biological mediators.18 The soluble lens steroidbinding protein may function in the same way.
The purpose of the present study was to identify the soluble protein responsible for glucocorticoid binding in lens extract and to characterize its steroid-binding properties.
| Materials and Methods |
|---|
|
|
|---|
Protein Purification
Soluble lens proteins were separated in PBSA by gel permeation
chromatography17
(GPC; 800 HRLC; Bio-Rad, Richmond, CA;
incorporating Zorbax G450 and G250 Bioseries columns; DuPont NEN,
Boston, MA, connected in series). A flow rate of 1 ml/min was used, and
the absorbance was measured at 280 nm (A280; 1706
UV/VIS; Bio-Rad). The polypeptide content of the isolated protein
fractions was examined using SDS-PAGE, as described
previously.20
An
-crystallin monoclonal antibody Sepharose-affinity gel was used
to purify
-crystallin. The production of the column and the method
of
-crystallin isolation were as described by Stevens and
Augusteyn.21
The eluted protein was renatured by dialysis
against Tris buffer (50 mM Tris, 2 mM EDTA, 0.02%
NaN3 [pH 8.0]) containing 7 M urea and
subsequently against the Tris buffer alone. The protein was further
dialyzed against PBSA and stored at 4°C.
Dexamethasone Binding
To identify the proteins interacting with dexamethasone, lens
extract or soluble lens proteins were incubated with 5.2 x
10-8 M
[6,7-3H]- dexamethasone (39.2 Ci/mmol;
DuPont NEN) for 3 hours at 20°C. For whole lens extracts, the soluble
and insoluble fractions were separated by centrifugation and the
distribution of radioactivity determined (1215 Rackbeta II or model
1409 liquid scintillation counter; Wallac, PerkinElmer Life Science,
Boston, MA). Correction for contamination of the insoluble fraction
with the soluble phase was made by reference to the distribution of
32Pi (9000 Ci/mmol; DuPont NEN) added before
centrifugation. The soluble proteins were separated by GPC as
described, individual fractions were collected, and the associated
radioactivity was determined.
All other dexamethasone-binding studies were performed essentially as follows. Proteins, ranging in concentration from 0.1 to 50 mg/ml, were incubated at 20°C with 5.2 x 10-8 M [6,7-3H]-dexamethasone for 3 hours, after which the protein-bound and free steroid were separated on a 1 x 10-cm chromatography column (Sephadex G-25; Amersham Pharmacia Biotech, Piscataway, NJ) equilibrated with PBSA.
Determination of steroid-binding parameters using Scatchard analysis
involved the addition of 5 to 315 x
10-9 M
[6,7-3H]-dexamethasone to a 2 mg/ml solution of
-crystallin and incubation for 3 hours at 20°C. Samples were taken
before separation of the bound and free steroid to estimate total
steroid concentration and allow the calculation of free steroid. The
amount of bound dexamethasone was calculated per mole of
-crystallin
subunit, using an average subunit molecular weight of 20,000.
Sequence Comparison
The sequences of bovine
A- and
B-crystallins were compared
with those of known glucocorticoid-binding proteins. Sequence
information was obtained from the Swiss-Prot database (Swiss Institute
of Bioinformatics, Geneva, Switzerland; available in the public domain
to academic users [licensing fee charged to commercial users] at
http//:www.expasy.org), and alignments were performed using the a
multiple sequence-alignment program (Clustal W, ver. 1.7; SGI, Mountain
View, CA).
| Results |
|---|
|
|
|---|
To identify the interacting species, the soluble proteins were
fractionated using GPC. As can be seen in Figure 1
, substantial radiolabel is associated with the high-molecular-weight
(HMW;
-crystallin) fraction and only small amounts (<5% of HMW)
with the medium-molecular-weight (MMW; ß-crystallin) fraction. The
radioactivity peak observed at approximately 29.5 minutes and
apparently associated with the low-medium-weight (LMW;
-crystallin)
proteins, is due to free dexamethasone. Injection of free radiolabel
produced a peak with the same retention time, and trichloroacetic acid
(TCA) precipitation showed there was no covalent incorporation.
|
-crystallin. To determine whether this was the protein
interacting with dexamethasone, binding studies were performed with
several concentrations of lens extract, HMW protein, and
affinity-purified
-crystallin.
The relative amounts of steroid bound by
-crystallin, HMW protein,
and lens extract were the same at all protein concentrations tested. At
25 mg/ml protein, the amounts bound were approximately 700, 1490, and
1580 femtomoles/mg protein for lens extract, HMW, and
-crystallin,
respectively. When the lens extract and HMW were expressed relative to
their
-crystallin content (45% and 95%, respectively), bound
dexamethasone corresponded to 1580 and 1560 femtomoles/mg,
respectively, essentially identical with that of the pure protein.
These data confirm that
-crystallin was the major soluble protein
interacting with the steroids. Binding studies with the two
-crystallin subunits,
A and
B, indicated these had similar
dexamethasone-binding capacities (data not shown).
To examine the strength of the interaction, the effects of variations
in dexamethasone concentration was examined. The data in Figure 2 reveal that the association of dexamethasone with
-crystallin
increased linearly over a 63-fold concentration range with no
indications of saturation being reached. The backward extrapolation of
the line from high concentrations passes through zero, indicating that
there was no specific binding. Similar linear binding was previously
observed with unfractionated lens extract.7
The Scatchard
plot of the data (Fig. 3)
shows a near-horizontal line that is indicative of nonspecific
partitioning.
|
|
-crystallin polypeptide sequences were compared with
those of several corticosteroid-binding proteins (CBPs). Little
homology was observed, except in the yeast CBP.23
As shown
in Figure 4 , this contained three widely separated sequence segments of 5, 7, and 5
residues that exhibited a high degree of homology with sequences in
-crystallin. Of the 17 residues, 11 were identical, and a further
three had amino acids with very similar properties. Each of the three
sequences appeared to be highly conserved in
-crystallins and in the
closely related small heat shock protein (shsp), hsp20. Unfortunately,
no information is available on the significance of these to steroid
binding or on the three-dimensional positioning of these areas in CBP.
|
| Discussion |
|---|
|
|
|---|
-crystallin.
Only a very small amount was found in the ß-crystallin fraction. This
can be attributed to covalent modification of these proteins, which has
previously been reported.14
15
The noncovalent interaction of dexamethasone with pure
-crystallin
is best described as nonspecific partitioning. The Scatchard plot was
horizontal for a wide range of concentrations, and there were no
indications of a saturable component. Similar observations have
previously been made with unfractionated lens extract.7
Partitioning of small molecules into proteins is not a commonly
observed phenomenon, but it takes place readily with lipid
micelles.24
-Crystallin has micelle-like
properties25
and exhibits similar partitioning with
molecules such as 1-anilinonaphthalene-8-sulfonic acid
(ANS)26
and acrylamide.27
The absence of a high-affinity binding site precludes any direct role
for
-crystallin in steroid-mediated regulation of lens function.
However, because of its ability to partition,
-crystallin could
accumulate steroids that may affect steroid sensitive molecules, such
as the lens membrane steroid-binding protein described by Cenedella et
al.12
Given the large amount of
-crystallin in the
lens, approximately 50 mg in a human lens, such a pool could be
substantial.
The partitioning may also bring the steroid into proximity with
reactive groups in the protein, principally lysine, effectively
increasing the local concentration, thereby promoting adduct formation.
This could explain the higher propensity of
-crystallin to form
covalent steroid adducts, compared with the other
crystallins.15
It has been suggested that adduct formation
produces conformational alterations that lead to cataract. However,
recent work from this and other laboratories has brought into question
the role of such adducts in steroid cataract.14
15
The ability of
-crystallin to accommodate large amounts of small
molecules, with no apparent effect on its size,27
suggests
that there may be cavities within the molecule. The presence of
cavities has long been suspected because of the large discrepancy
between the apparent hydrodynamic volume of the protein and that
expected from its molecular mass.28
29
Recently, Haley et
al.,30
using cryoelectron microscopy, observed an internal
cavity in
B-crystallin aggregates, and Kim et al.31
found a cavity in the closely related shsp Methanococcus
jannischii. The cavities may participate in the nonspecific
steroid partitioning observed in the present study, as well as in the
partitioning of ANS26
and acrylamide27
and in
the association with membrane lipids32
and denatured
proteins.33
Sequence homology was found between
-crystallin and CBP, albeit
limited to three short segments. It is possible that these segments are
involved in the interaction with steroids. The three-dimensional
structures of
-crystallin and the CBP are unknown, but information
from the closely related shsp M. jannischiis crystal
structure31
and the polypeptide folding pattern of the
-crystallin domain34
allow some speculation on the
sites involved in the partitioning.
The three sequences are all located in the conserved
-crystallin
domain of the shsp family and correspond to the structural elements
named C1, C3, and B3 by Koteiche and Mchaourab.34
Each
participates in the extensive ß-pleated sheet network comprising
seven strands arranged in two sheets. The C1 and B3 strands are
antiparallel and lie alongside each other, generating a hydrophobic
surface comprising LeuValVal from ß4 and AlaLeu from ß8. We suggest
this surface forms part of a hydrophobic pocket into which the steroids
can partition. Support for this suggestion is provided by the
observation that the C1 sequence is within one of the hydrophobic sites
(
A7988) involved in the binding of ANS and
in the chaperone activity.35
The configuration of the
remaining segment is unclear, because it occurs in the region where the
M. jannischii shsp has nine residues more than the
-crystallins. Three-dimensional structures for both
-crystallin
and CBP are required to evaluate these possibilities.
Much remains to be learned about
-crystallin and its contribution to
lens structure and function. Detailed investigations of its unique
characteristics, such as the partitioning of small molecules, will
provide a better insight into the role of the protein in the lens.
| Footnotes |
|---|
Submitted for publication June 30, 2000; revised January 19, 2001; accepted March 5, 2001.
Commercial relationships policy: N.
Corresponding author: Robert Cornelis Augusteyn, National Vision Research Institute of Australia, 386 Cardigan St, Carlton Vic 3053, Australia. r.augusteyn{at}optometry.unimelb.edu.au
| References |
|---|
|
|
|---|
-crystallin FEBS Lett 222,1-5[Medline][Order article via Infotrieve]
-crystallin Eur J Biochem 243,792-797[Medline][Order article via Infotrieve]
-crystallin Biochim Biophys Acta 1162,61-71[Medline][Order article via Infotrieve]
B-crystallin, has a variable quaternary structure J Mol Biol 277,27-35[Medline][Order article via Infotrieve]
-crystallin with isolated lens plasma membranes Biochim Biophys Acta 596,57-63[Medline][Order article via Infotrieve]
-crystallin can function as a molecular chaperone Proc Natl Acad Sci USA 89,10449-10453
-crystallin domain in
A-crystallin determined by site-directed spin labeling J Mol Biol 294,561-577[Medline][Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. R. James, L. Robertson, E. Ehlert, P. Fitzgerald, N. Droin, and D. R. Green Presence of a Transcriptionally Active Glucocorticoid Receptor {alpha} in Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5269 - 5276. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lyu, J.-A Kim, S. K. Chung, K.-S. Kim, and C.-K. Joo Alteration of Cadherin in Dexamethasone-Induced Cataract Organ-Cultured Rat Lens Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2034 - 2040. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gupta and B. J. Wagner Expression of the Functional Glucocorticoid Receptor in Mouse and Human Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2041 - 2046. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |